UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

Emerging infectious diseases, 2009-04, Vol.15 (4), p.552-560

2009

Volltextzugriff (PDF)

Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy

PloS one, 2013-08, Vol.8 (8), p.e71045

2013

Volltextzugriff (PDF)

Abstract P6-04-08: FOXA1 expression: regulated by EZH2 and associated with favorable outcome to tamoxifen in advanced breast cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-04-08

2012

Volltextzugriff (PDF)

Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling

Journal of clinical oncology, 2005-02, Vol.23 (4), p.732-740

2005

Volltextzugriff (PDF)

High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer

Cancer research (Chicago, Ill.), 2001-07, Vol.61 (14), p.5407-5414

2001

Volltextzugriff (PDF)

RNA Expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: Correlation with chemotherapeutic response

Clinical cancer research, 2003-02, Vol.9 (2), p.827-836

2003

Volltextzugriff (PDF)

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

Cancer research (Chicago, Ill.), 2000-02, Vol.60 (3), p.636-643

2000

Volltextzugriff (PDF)

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424)

Cancer research (Chicago, Ill.), 2002-08, Vol.62 (16), p.4617-4622

2002

Volltextzugriff (PDF)

Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer

Clinical cancer research, 2004-04, Vol.10 (7), p.2289-2298

2004

Volltextzugriff (PDF)

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

British journal of cancer, 1999-01, Vol.79 (2), p.300-307

1999

Volltextzugriff (PDF)

How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study

Clinical cancer research, 2005-10, Vol.11 (20), p.7311-7321

2005

Volltextzugriff (PDF)

Contribution of nitrification and denitrification to the NO and N2O emissions of an acid forest soil, a river sediment and a fertilized grassland soil

Soil biology & biochemistry, 1997-11, Vol.29 (11-12), p.1655-1664

1997

Volltextzugriff (PDF)

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (8), p.2155-2162

2000

Volltextzugriff (PDF)

Abstract P6-08-10: Mutational signatures impact the breast cancer transcriptome and distinguish mitotic from immune response pathways

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-08-10

2016

Volltextzugriff (PDF)

Combined Vascular Endothelial Growth Factor and TP53 Status Predicts Poor Response to Tamoxifen Therapy in Estrogen Receptor-positive Advanced Breast Cancer

Clinical cancer research, 2003-04, Vol.9 (4), p.1253-1258

2003

Volltextzugriff (PDF)

Prognostic significance of cathepsins B and L in primary human breast cancer

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1013-1021

1998

Volltextzugriff (PDF)

Abstract S6-05: High levels of APOBEC3B, a DNA deaminase and an enzymatic source of C-to-T transitions, are a validated marker of poor outcome in estrogen receptor-positive breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.S6-S6-05

2013

Volltextzugriff (PDF)

Bcar1/p130Cas protein and primary breast cancer : Prognosis and response to tamoxifen treatment

JNCI : Journal of the National Cancer Institute, 2000-01, Vol.92 (2), p.120-127

2000

Volltextzugriff (PDF)

Clinical relevance of biologic factors in male breast cancer

Breast cancer research and treatment, 2001-08, Vol.68 (3), p.249-260

2001

Volltextzugriff (PDF)

Tumor tissue levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) and survival following adjuvant chemotherapy in pre-menopausal lymph node-positive breast cancer patients (N=525)

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.6054

2009

Volltextzugriff (PDF)

Real-time simulation of IK1 in cardiomyocytes derived from human induced pluripotent stem cells

2015 Computing in Cardiology Conference (CinC), 2015, p.157-160

2015

Volltextzugriff (PDF)

Contribution of nitrification and denitrification to the NO and N sub(2)O emissions of an acid forest soil, a river sediment and a fertilized grassland soil

Soil biology & biochemistry, 1997-12, Vol.29 (11-12), p.1655-1664

1997

Volltextzugriff (PDF)

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer

British journal of cancer, 1999-02, Vol.79 (5-6), p.888-894

1999

Volltextzugriff (PDF)

Relationship Between Transcription Factors and S14 Gene Expression in Response to Thyroid Hormone and Age

Experimental biology and medicine (Maywood, N.J.), 1994-10, Vol.207 (1), p.97-101

1994

Volltextzugriff (PDF)

Breast-Conserving Therapy: Proteases as Risk Factors in Relation to Survival After Local Relapse

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1449-1457

1999

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(232)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy

Abstract P6-04-08: FOXA1 expression: regulated by EZH2 and associated with favorable outcome to tamoxifen in advanced breast cancer

Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling

High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer

RNA Expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: Correlation with chemotherapeutic response

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424)

Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study

Contribution of nitrification and denitrification to the NO and N2O emissions of an acid forest soil, a river sediment and a fertilized grassland soil

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer

Abstract P6-08-10: Mutational signatures impact the breast cancer transcriptome and distinguish mitotic from immune response pathways

Combined Vascular Endothelial Growth Factor and TP53 Status Predicts Poor Response to Tamoxifen Therapy in Estrogen Receptor-positive Advanced Breast Cancer

Prognostic significance of cathepsins B and L in primary human breast cancer

Abstract S6-05: High levels of APOBEC3B, a DNA deaminase and an enzymatic source of C-to-T transitions, are a validated marker of poor outcome in estrogen receptor-positive breast cancer

Bcar1/p130Cas protein and primary breast cancer : Prognosis and response to tamoxifen treatment

Clinical relevance of biologic factors in male breast cancer

Tumor tissue levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) and survival following adjuvant chemotherapy in pre-menopausal lymph node-positive breast cancer patients (N=525)

Real-time simulation of IK1 in cardiomyocytes derived from human induced pluripotent stem cells

Contribution of nitrification and denitrification to the NO and N sub(2)O emissions of an acid forest soil, a river sediment and a fertilized grassland soil

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer

Relationship Between Transcription Factors and S14 Gene Expression in Response to Thyroid Hormone and Age

Breast-Conserving Therapy: Proteases as Risk Factors in Relation to Survival After Local Relapse

Suchergebnisse filtern